Good News: There Might Be Yet Another Off-Label Treatment for the Wuhan Flu (and Against Tyranny)

Probenecid, an FDA-approved gout treatment with “powerful antiviral properties” and minimal side effects, is “a prime candidate” for treating COVID-19 according to a new study.

SciTechDaily reports on recent research from the University of Georgia, where they found that probenecid “works as a prophylactic prior to virus exposure and as a post-exposure treatment in animal models against SARS-CoV-2 and flu.”

Ralph Tripp, lead author of the study, concluded, “This antiviral works for all RNA respiratory viruses we tested, including SARS-CoV-2. RSV, coronavirus and flu all circulate in the same season. Bottom line is you can potentially reduce infection and disease using this one oral drug.”

This is potentially great news.

COVID-19 hospitalizations have gone up in recent weeks as the delta variant makes its way through the population. Even though delta is far less deadly than the initial version of the Wuhan Flu, nobody wants to end up stuck in a hospital or on a ventilator.

Tripp’s company, TrippBio, is set to begin clinical trials of probenecid against COVID later this year.

Although I do wish they’d hurry it up.

Floridians and Texans have already gotten through the worst of the delta spike, but seasonality means it’s heading north for the winter.

The wave is about to increase up north. It's decreasing in the south.
As winter and indoors comes for the north, so will COVID.
As summer and A/C leaves the south, so will COVID.
Lesson: Keep your windows open.
Also, your moral preening does not affect COVID.
— Melissa Mackenzie (@MelissaTweets) September 10, 2021

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.